tirzepatide pregnancy breastfeeding guidance and breastfeeding: New research offers hope for postpartum moms GLP-1s (Weight loss injections) AND

The inspection record, enforcement actions, and transparency of a facility tell you far more than registration status alone

After 12 months of treatment, people who took: Tirzepatide lost an average of 15% of their body weight Semaglutide lost an average of 8% of their body weight While the potential weight loss outcomes with both drugs are promising, these medications arent a cure-all

Connecting copper and cancer: from transition metal signalling to metalloplasia

Hanssen, R., Kretschmer, A

Using a new needle for the injection ensures it is as sharp and painless as possible and maintains strict sterility

While large-scale randomized clinical trials are still needed, the existing research makes a compelling case for adding copper peptides to a comprehensive hair care routine